“The American Reinvestment and Recovery Act gives comparative-effectiveness research (CER) a large boost in funding over the next 2 years. Despite a consensus that better information about the relative effectiveness of different medical interventions is needed to improve the quality and value of care, some view CER with skepticism.”
Home » Links » Does Comparative-Effectiveness Research Threaten Personalized Medicine? by Garber and Tunis
